Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow
Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow
批准号:
14570694
负责人:
KATOH Youichi
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BACKGROUND: Bone marrow stromal cells (BMSCs) have many characteristics of mesenchymal stem cells that can differentiate into smooth muscle cells (SMCs). However, there have been few studies closely following the cell development of smooth muscle lineage among BMSCs. METHODS AND RESULTS: To investigate the possible existence of a cell population committed to the SMC lineage among bone marrow adhesion cells, we tried to detect and follow the in vitro differentiation of such a cell type by using a promoter-sorting method with a human SM22alpha promoter (-480 bp)/green fluorescent protein (GFP) construct. The construct was transfected to adhesion cells that appeared 5 days after the seeding of mononuclear cells from bone marrow. GFP was first detectable 5 days aftel the transfection in a cell population [Ad(G) cells], which expressed PDGF-beta but neither mature (calponin) nor immature (SMemb) SMC-specific proteins at that time. However, the cells were eventually grown into individual clones that expressed SMC-specific proteins (alpha-smooth muscle actin, calponin, and SM-1), suggesting that Ad(G) cells have partly at least progenitor properties. Because early studies have reported that PDGF-beta signaling plays pivotal roles in the differentiation of mesenchymal smooth muscle progenitor cells, Ad(G) cells might be putative mesenchymal smooth muscle progenitors expressing PDGF-beta. CONCLUSIONS: We demonstrated the presence of a cell population fated to become SMCs and followed their differentiation into SMCs among BMSCs.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yuji Kashiwakura, Youichi Katoh et al.: "Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22・ promoter -In vitro differentiation of putative smooth muscle progenitor cells of bone marrow -"Circulation. (in press). (2003)
Yuji Kashiwakura、Youichi Katoh 等人:“通过人 SM22 启动子分离骨髓基质细胞衍生的平滑肌细胞 - 假定的骨髓平滑肌祖细胞的体外分化 -”循环(2003 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yuji Kashiwakura, Youichi Katoh et al.: "Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22α promoter. - In vitro differentiation of putative smooth muscle progenitor cells of bone marrow -"Circulation. 107. 2078-2081 (2003)
Yuji Kashiwakura、Youichi Katoh 等人:“通过人 SM22α 启动子分离骨髓基质细胞衍生的平滑肌细胞。- 假定的骨髓平滑肌祖细胞的体外分化 -”Circulation。 2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kashiwakura Y, Katoli Y, Tamayose K, Konishi H, Takaya N, Yuhara S, Yamada M, Sugimoto K, Daida H: "Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progeni
Kashiwakura Y、Katoli Y、Tamayose K、Konishi H、Takaya N、Yuhara S、Yamada M、Sugimoto K、Daida H:“通过人 SM22α 启动子分离骨髓基质细胞来源的平滑肌细胞:假定的体外分化
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hakuoh Konishi, Youichi Katoh et al.: "Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury."Circulation.. 105. 912-916 (2002)
Hakuoh Konishi、Youichi Katoh 等人:“胶原蛋白通过基于免疫受体酪氨酸的激活基序激活的血小板在血管损伤后新内膜增生的起始和生成中发挥着关键作用。”Circulation.. 105. 912-916 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
柏倉祐司, 加藤洋一, 代田浩之: "血管の形成と障害-スタチンの分子生物学的特性"Heart View. Vol.7 No.12. 284-287 (2003)
Yuji Kashiwakura、Yoichi Kato、Hiroyuki Shirota:“血管形成和紊乱 - 他汀类药物的分子生物学特征”Heart View Vol.7 No.12 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
-
批准号:82370801
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李峰
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
-
批准号:82371517
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨立群
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
-
批准号:82370780
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:夏术阶
-
依托单位:
TNFAIP8/Hippo/SIX1轴调控软骨干细胞分化能力在颞下颌骨关节炎中的机制研究
-
批准号:82370980
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:沈佩
-
依托单位:
细胞命运决定中不同蛋白水平OCT4A差异性调控CITED2转录的机制研究
-
批准号:32100597
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周艳文
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位: